Keisuke Kusudo
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Association between Intravenous Ketamine Treatment and Cognitive Function in Patients with Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Trial.
Journal: Pharmacopsychiatry
Published: July 07, 2026
Brain iron-sensitive markers (magnetic susceptibility and R2*) predict antidepressant response to ketamine in treatment-resistant depression.
Journal: Psychiatry research. Neuroimaging
Published: October 17, 2025
Psychiatric Symptoms Associated with Corticosteroid Use: A Systematic Review and Meta-analysis.
Journal: CNS drugs
Published: July 27, 2025
Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations.
Journal: Psychiatry and clinical neurosciences
Published: July 24, 2025
The association between amygdalar volume changes and depressive symptom improvements after repeated ketamine infusion in treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with the following open-label study.
Journal: Journal of psychiatric research
Published: June 13, 2025
Glutamate plus glutamine to GABA ratio as a predictor of ketamine response in treatment-resistant depression: A double-blind, randomized, open-label extension study.
Journal: Journal of affective disorders
Published: January 22, 2025
Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial.
Journal: Psychiatry and clinical neurosciences
Published: May 10, 2024
Development of the Japanese version of the Challenging Experience Questionnaire.
Journal: Neuropsychopharmacology reports
Published: April 15, 2024
Relapse of Tardive Dyskinesia Following Successful Treatment With Amantadine: A Case Report.
Journal: Journal of clinical psychopharmacology
Published: March 18, 2024
Disease Progression Patterns of Brain Morphology in Schizophrenia: More Progressed Stages in Treatment Resistance.
Journal: Schizophrenia bulletin
Published: November 26, 2023
Development of the Japanese version of the Ego-Dissolution Inventory (EDI).
Journal: Neuropsychopharmacology reports
Published: October 12, 2023
Last Updated: 09/26/2026